Search

everythinglearnresearchcommunity

for

Search:↓

IsoPSA test works accurately even if patients take certain prostate medications.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

A male with aromatase deficiency improved bone health with estradiol treatment.

A new compound effectively inhibits human 5α-reductase 1.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

In vitro bioassays are better than traditional methods for measuring androgen activity but aren't ready for routine use yet.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Testosterone affects hair loss, acne, and excessive hair growth, and antiandrogens can help treat these conditions.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

Caucasian men have more chest hair and higher levels of certain androgen products than Chinese men.

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.